ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced its Burlington, MA sterile drug product facility has been named “Manufacturer of the Year” by the Massachusetts Legislative Manufacturing Caucus. The award was presented at the 10th Annual Manufacturing Awards Ceremony, held on Oct. 21 at Gillette Stadium. Curia’s Burlington site has been part of the company’s network since 2010. The facility specializes in drug product manufacturing of vials and prefilled syringes for late-stage clinical trials and commercial products. The site is known for its capabilities to handle solvent-based processes, highly viscous products and controlled substances. It also houses an on-site process development lab supporting mixing studies, scale-up and formulation development. “Curia employees play a crucial role in producing medicines patients can trust, guided by the most stringent quality standards,” said Mari-Kate Alter, General Manager and Site Head, Curia Burlington. “While our direct clients are pharmaceutical companies, we come to work each day with patients in mind. We are honored to contribute to improving patient lives and are proud to be recognized for our role in Massachusetts’ manufacturing ecosystem.” Curia’s sterile drug product capabilities include working with complex APIs, potent and cytotoxic compounds, highly viscous formulations and controlled substances, from clinical to commercial scale, at four advanced facilities around the world. The Burlington site is part of Curia’s global network of sterile fill-finish facilities, which includes clinical manufacturing in Camarillo, CA and Glasgow, UK, as well as commercial and clinical capabilities in Albuquerque, NM. The Manufacturing Caucus, formed in 2014, includes more than 70 Massachusetts legislators focused on strengthening the state’s manufacturing sector through workforce training, innovation support and apprenticeship programs. “This is an exciting time for committed manufacturers like Curia who embody ‘Making It in Massachusetts,’” said

BANDUNG, Indonesia, Oct. 21, 2025 (GLOBE NEWSWIRE) — Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers’ Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN’s founding in 2000, Bio Farma has been a key driver in advancing vaccine self-reliance and public health capacity in developing countries. Collaboration between Bio Farma and DCVMN has been established since the inception of the network. At the first DCVMN Annual General Meeting in Noordwijk in 2000, Bio Farma was one of ten founding members dedicated to advancing vaccine collaboration. In April 2001, Bio Farma in Bandung hosted the 2nd AGM, where the network formalized the DCVMN’s structure and governance. Chaired by then-President Director Thamrin Poeloengan, this meeting established Indonesia as a hub for vaccine collaboration and knowledge-sharing among developing countries. Shadiq Akasya, current President Director of Bio Farma, stated that the company’s participation in DCVMN reflects Indonesia’s commitment to contributing to global health beyond national interests. “Bio Farma’s involvement in DCVMN since its establishment is not merely about representation, but about making a tangible contribution toward global vaccine self-reliance. Through collaboration and innovation, we are committed to delivering equitable and sustainable health solutions for all,” said Shadiq. “We believe that the true strength of the developing countries’ vaccine industry lies in collaboration. Through our active role in DCVMN, we aim to ensure that every nation has access to safe, high-quality, and affordable vaccines, a real manifestation of Indonesia’s contribution to global health security,” he added. In 2004, Bio Farma, together with other DCVMN members, played a vital role in expanding access to the pentavalent (DPT-HepB-Hib) vaccine through a technology-transfer collaboration with the Netherlands Vaccine Institute. This achievement demonstrated that Bio Farma’s contributions within the DCVMN network are

HONG KONG, Oct. 20, 2025 (GLOBE NEWSWIRE) — This month, Hong Kong welcomes one of Asia’s most anticipated culinary events. From 23 to 26 October 2025, the Hong Kong Wine & Dine Festival will be transforming the Central Harbourfront into an epicurean festival of masterful dishes, innovative wine pairings and high-profile collaborations. Guests can look forward to the return of signature highlights, from the BEA Grand Wine Pavilion – showcasing rare wine vintages and emerging global discoveries – to the Tasting Room, where acclaimed chefs unveil exclusive limited-time creations. And you won’t want to miss Towngas Gourmet Avenue, which brings together 12 of the city’s most lauded restaurants. Among the standout moments will be the chance to hear directly from leading voices in the industry, including celebrated chefs from both the Tasting Room and Towngas Gourmet Avenue. Celebrated chefs showcase Cantonese fusion at the Tasting Room For a once-in-a-lifetime culinary experience, the Tasting Room is a must. The venue’s restaurant, under the theme Taste the Extraordinary: Beyond Cantonese Flavour, will bring together a star-studded lineup of chefs. Celebrated chefs at Tasting Room Renowned chefs join hands at the Tasting Room of the Wine & Dine Festival (Left to right: Menex Cheung, Cheung Yat Fung, Jung Ji-sun, Jayson Tang, Andrew Wong) London-based chef Andrew Wong, owner of A. Wong and the first Chinese restaurant outside of Asia to hold a two-Michelin stars, can’t wait to visit Hong Kong for the premier culinary event. “I’m honoured to be part of the Hong Kong Wine & Dine Festival,” he says. “I look forward to working alongside so many talented local chefs to present an unforgettable experience that brings modern Chinese flavours to life while paying homage to Cantonese traditions.” Cheung Yat Fung, the acclaimed chef behind three-Michelin-starred Chao Shang Chao (Chaoyang), sees the

CAIRO, EGYPT – Media OutReach Newswire – 21 October 2025 – The Egyptian Company for Cosmetics, on behalf of ECC Group — Egyptian Company for Cosmetics, Infinity Clinic Pharma, Vision Cosmetics, and the Source Beauty team has been officially certified as one of the Best Places to Work in Egypt for 2025. This distinguished recognition highlights ECC Group’s sustained commitment to delivering exceptional products, fostering employee development, and cultivating a culture of excellence across all its entities. The certification process, conducted through an independent assessment and employee survey, evaluated key organizational dimensions including leadership, engagement, trust, and workplace well-being. This achievement affirms ECC Group’s continued investment in human capital and its strategic focus on building a positive and inclusive work environment that enables people to thrive, innovate, and contribute to shared success. In a statement from, Mohamed Salah, CEO & Founder of ECC, he said: “Achieving the Best Place to Work certification is more than a milestone—it reflects the culture we have built together at ECC. Our people have always been our greatest asset, and this recognition is the result of their passion, commitment, and unity. What makes this milestone meaningful is that it represents who we are: a workplace founded on respect, collaboration, and shared purpose. I am proud of every individual who contributed to this success, and I am confident that we will continue to grow stronger together.” Dr. Ahmed Abo El-Hmayel, CEO of Infinity Clinic Pharma, Vision Cosmetics & Source Beauty, he said:”Being certified as a Best Place to Work is not just an achievement, it reflects the culture we have built together. At ECC, our greatest strength has always been our people—their passion, dedication, and teamwork. This recognition is a testament to the environment we strive for every day: one of inclusivity, collaboration, and shared purpose.” The Best Places to Work certification underscores ECC